In the feverish atmosphere of China’s A-share market, a new form of corporate alchemy has taken hold: the 'Big Tech Friend Group.' By peppering public disclosures with mentions of global titans like Nvidia, Intel, or Tesla, listed companies are transforming mediocre balance sheets into soaring stock valuations. However, as the Securities Times recently detailed, many of these 'partnerships' are more aspirational than financial, leaving retail investors trapped in a cycle of speculative booms and crushing busts.
The strategy often relies on 'vague disclosure'—a practice of using ambiguous language to hint at elite supply chain status without providing concrete data. In one high-profile instance, a company saw its shares hit the daily limit after announcing a 'partnership' with a global chip leader, only to clarify days later that it had no actual business transactions with the firm. Such tactics exploit the 'halo effect,' where the mere proximity to a global innovator is treated by the market as a proxy for future profitability, regardless of actual revenue impact.
At the heart of this issue is a significant divergence in regulatory standards between China and more mature capital markets like the United States. Under current Chinese rules, companies are generally only required to name specific customers or suppliers if a single contract exceeds 50% of audited revenue. This creates a massive 'gray zone' where companies can boast about prestigious associations that contribute less than 1% to their bottom line, safely tucked under the mandatory disclosure threshold.
By contrast, the U.S. Securities and Exchange Commission mandates disclosure when a customer accounts for just 10% of revenue. The Chinese framework’s high threshold for mandatory naming effectively allows 'low-value, high-prestige' relationships to be used as marketing tools. This lack of transparency forces investors to navigate a maze of indirect suppliers and non-exclusive agreements that often possess no real technical moats or financial significance.
To curb this 'concept hype,' regulators are being urged to shift from reactive punishment to proactive intervention. Proposed measures include 'negative lists' for vague terminology, mandatory trading halts for suspicious price movements, and requiring companies to quantify the 'commercial substance' of their partnerships. For a market increasingly focused on 'patient capital' and high-quality development, purging these speculative bubbles is becoming a primary focus for the China Securities Regulatory Commission.